Clinical trial
Intravesical Gentamicin to Prevent Recurrent UTI
NCT06332781 is registered in ClinicalTrials.gov with Women and Infants Hospital of Rhode Island as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intravesical Gentamicin to Prevent Recurrent UTI
- Lead sponsor
- Women and Infants Hospital of Rhode Island
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 28, 2025
- Completion date
- March 31, 2026
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
recurrent uti